Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer-Reference-Cited by-同舟云学术

Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer

Published:2011-08-18 Issue:2 Volume:109 Page:226-232
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Shore Neal,Cookson Michael S.,Gittelman Marc C.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10370.x/fullpdf

Reference24 articles.

1. Cancer Statistics, 2010;Jemal;CA Cancer J Clin,2010

2. National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer http://www.nccn.org/professionals/physician_gls/PDF/prostate.pdf

3. Clinical review 134: the endocrinology of prostate cancer;Taplin;J Clin Endocrinol Metab,2001

4. A review of the pharmacokinetic and pharmacological properties of a once-yearly administered histrelin acetate implant in the treatment of prostate cancer;Schlegel;BJU Int,2009

5. Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer;Keating;J Natl Cancer Inst,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Versatile hydrogel-based drug delivery platform for multimodal cancer therapy from bench to bedside;Applied Materials Today;2024-08

2. Multicomponent Hydrogels for Cancer Diagnosis and Therapy;Multicomponent Hydrogels;2023-05-22

3. Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021;Journal of Hematology & Oncology;2022-10-08

4. Targeting signaling pathways in prostate cancer: mechanisms and clinical trials;Signal Transduction and Targeted Therapy;2022-06-24

5. Hydrogels for Tissue Engineering: Addressing Key Design Needs Toward Clinical Translation;Frontiers in Bioengineering and Biotechnology;2022-05-05